IL10 and esophageal cancer: (20) found that the -1082g/a rs1800896 genetic variation can be used as a candidate biomarker to predict the susceptibility of esophageal cancer by comparing the IL10 genotypes of 246 pathologically confirmed esophageal cancer patients and 492 healthy control subjects.